|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-20
|
|
pubmed:abstractText |
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) reduce serum cholesterol level and cardiovascular morbidity and mortality. However, the effect of statins on glucose metabolism is unclear. Some studies have suggested that statins may cause hyperglycemia by increasing calcium concentration in the islet cells leading to decrease in insulin release or by decreasing GLUT 4-mediated peripheral glucose uptake.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1081-5589
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
495-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19188844-Aged,
pubmed-meshheading:19188844-Blood Glucose,
pubmed-meshheading:19188844-Databases, Factual,
pubmed-meshheading:19188844-Diabetes Complications,
pubmed-meshheading:19188844-Diabetes Mellitus,
pubmed-meshheading:19188844-Dyslipidemias,
pubmed-meshheading:19188844-Fasting,
pubmed-meshheading:19188844-Food Deprivation,
pubmed-meshheading:19188844-Humans,
pubmed-meshheading:19188844-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19188844-Hypertension,
pubmed-meshheading:19188844-Male,
pubmed-meshheading:19188844-Middle Aged,
pubmed-meshheading:19188844-Treatment Outcome,
pubmed-meshheading:19188844-United States,
pubmed-meshheading:19188844-Veterans
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.
|
|
pubmed:affiliation |
Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
|
|
pubmed:publicationType |
Journal Article
|
